Welcome to CDC stacks | Host genes and HIV infection: implications and applications. - 15419 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Host genes and HIV infection: implications and applications.
  • Published Date:
    1997 Jul-Sep
  • Source:
    Emerg Infect Dis. 3(3):401-402.
Filetype[PDF-14.31 KB]


No Related Documents.
You May Also Like:
  1. National Office of Public Health Genomics (NOPHG) 2006 program review book
    Corporate Author:
    National Office of Public Health Genomics (U.S.)
    Published:
    10/13/06
    Description:
    Public health genomics is a multidisciplinary field that uses the effective and responsible translation of genome-based knowledge and technologies to improve population health. Public health genomics uses population-based data on genetic variation an...
    File Type:
    Filetype[PDF - 797.26 KB]
  2. 10 years of public health genomics at CDC 1997-2007
    Personal Author:
    Bedrosian, Sara
    Corporate Author:
    National Office of Public Health Genomics (U.S.)
    Published:
    December 2007
    Description:
    "Public health genomics is a multidisciplinary field concerned with the effective and responsible translation of genome-based knowledge and technologies to improve population health. Public health genomics uses populationbased data on genetic variati...
    File Type:
    Filetype[PDF - 3.99 MB]
  3. Physiological functions and clinical implications of fibrinogen-like 2: A review
    Personal Author:
    Yang, Genyan; Hooper, W Craig;
    Published:
    Aug 25 2013
    Source:
    World J Clin Infect Dis. 2013; 3(3):37-46.
    Description:
    Fibrinogen-like 2 (FGL2) encompasses a transmembrane (mFGL2) and a soluble (sFGL2) form with differential tertiary structure and biological activities. Typically, mFGL2 functions as prothrombinase that is capable of initiating coagulation in tissue w...
    File Type:
    Filetype[PDF - 192.46 KB]
  4. Antibody Response to Pneumocystis jirovecii
    Personal Author:
    Daly, Kieran R.; Huang, Laurence; Morris, Alison; Koch, Judy; Crothers, Kristina; Levin, Linda; Eiser, Shary; Satwah, Supriya; Zucchi, Patrizia; Walzer, Peter D.;
    Published:
    Aug 2006
    Source:
    Emerg Infect Dis. 12(8):1231-1237.
    Description:
    We conducted a prospective pilot study of the serologic responses to overlapping recombinant fragments of the Pneumocystis jirovecii major surface glycoprotein (Msg) in HIV-infected patients with pneumonia due to P. jirovecii and other causes. Simila...
    File Type:
    Filetype[PDF - 227.71 KB]
  5. Applications of biotechnology for infectious diseases
    Corporate Author:
    Centers for Disease Control (U.S.). Center for Infectious Diseases (U.S.). Centers for Disease Control (U.S.), Technology Transfer Office..
    Published:
    1990s
    Description:
    CDC is actively engaged in the practical applications of this explosion of new technology to disease problems through a Congressional mandate. Until 1986, the principal methods used by the Centers for Disease Control (CDC) to transfer technology outs...
    File Type:
    Filetype[PDF - 13.57 MB]